Hotchkis & Wiley Capital Management LLC trimmed its position in LifePoint Health, Inc. (NASDAQ:LPNT) by 11.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 415,707 shares of the company’s stock after selling 52,800 shares during the quarter. Hotchkis & Wiley Capital Management LLC owned approximately 1.04% of LifePoint Health worth $27,915,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of LifePoint Health by 10.8% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock worth $113,000 after buying an additional 164 shares during the period. LS Investment Advisors LLC grew its position in shares of LifePoint Health by 43.7% during the 2nd quarter. LS Investment Advisors LLC now owns 1,785 shares of the company’s stock worth $120,000 after buying an additional 543 shares during the period. US Bancorp DE grew its position in shares of LifePoint Health by 1.6% during the 1st quarter. US Bancorp DE now owns 1,931 shares of the company’s stock worth $127,000 after buying an additional 30 shares during the period. Bank of Montreal Can grew its position in shares of LifePoint Health by 18.7% during the 1st quarter. Bank of Montreal Can now owns 1,946 shares of the company’s stock worth $128,000 after buying an additional 306 shares during the period. Finally, Teacher Retirement System of Texas acquired a new position in shares of LifePoint Health during the 1st quarter worth about $210,000. Hedge funds and other institutional investors own 99.53% of the company’s stock.

LifePoint Health, Inc. (LPNT) opened at 56.75 on Monday. The stock’s 50 day moving average price is $57.49 and its 200 day moving average price is $61.98. The company has a market cap of $2.28 billion, a PE ratio of 12.71 and a beta of 0.85. LifePoint Health, Inc. has a 12-month low of $50.60 and a 12-month high of $70.95.

LifePoint Health (NASDAQ:LPNT) last released its earnings results on Tuesday, August 1st. The company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.90 by $0.06. LifePoint Health had a return on equity of 7.40% and a net margin of 2.61%. The business had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter last year, the firm posted $0.69 earnings per share. The firm’s revenue was up .2% on a year-over-year basis. Equities research analysts anticipate that LifePoint Health, Inc. will post $4.06 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Hotchkis & Wiley Capital Management LLC Lowers Position in LifePoint Health, Inc. (LPNT)” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another website, it was illegally copied and republished in violation of international trademark and copyright laws. The original version of this article can be read at https://www.thecerbatgem.com/2017/09/18/hotchkis-wiley-capital-management-llc-lowers-position-in-lifepoint-health-inc-lpnt.html.

In related news, Chairman William F. Carpenter III sold 17,653 shares of the firm’s stock in a transaction that occurred on Monday, July 17th. The stock was sold at an average price of $65.06, for a total transaction of $1,148,504.18. Following the completion of the sale, the chairman now owns 439,841 shares of the company’s stock, valued at $28,616,055.46. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 7.28% of the company’s stock.

Several equities analysts have recently issued reports on LPNT shares. ValuEngine upgraded LifePoint Health from a “hold” rating to a “buy” rating in a research report on Thursday, August 17th. BidaskClub lowered LifePoint Health from a “hold” rating to a “sell” rating in a research report on Tuesday, August 1st. Zacks Investment Research upgraded LifePoint Health from a “sell” rating to a “hold” rating in a research report on Monday, August 21st. Morgan Stanley started coverage on LifePoint Health in a research report on Tuesday, June 6th. They set an “equal weight” rating and a $65.00 target price for the company. Finally, TheStreet lowered LifePoint Health from a “b-” rating to a “c+” rating in a research report on Wednesday, August 16th. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $66.18.

LifePoint Health Company Profile

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Want to see what other hedge funds are holding LPNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifePoint Health, Inc. (NASDAQ:LPNT).

Institutional Ownership by Quarter for LifePoint Health (NASDAQ:LPNT)

Receive News & Stock Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related stocks with our FREE daily email newsletter.